https://news-usa.info/2026/10/08/ge-healthcare-to-buy-sofie-biosciences-for-945-million-to-strengthen-radiopharma-business-reuters/
GE HealthCare has announced its agreement to acquire Sofie Biosciences for $945 million, marking a strategic move to bolster its radiopharmaceutical portfolio. The acquisition, announced on [date], aims to enhance GE HealthCare’s capabilities in molecular imaging and targeted radiopharmaceutical therapies, expanding its footprint in the growing precision medicine market. This deal underscores GE HealthCare’s commitment to advancing diagnostic and therapeutic technologies, positioning the company for accelerated growth in the radiopharma sector.
GE HealthCare Expands Radiopharma Portfolio with Sofie Biosciences Acquisition
GE HealthCare has taken a significant step to bolster its position in the radiopharmaceutical sector through the acquisition of Sofie Biosciences for $945 million. This strategic move is expected to accelerate GE HealthCare’s development and delivery of advanced molecular imaging solutions, enhancing diagnostic accuracy and patient outcomes in oncology,…
—-
Author : Miles Cooper
Publish date : 2026-10-08 01:58:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8
